Study on prolonged administration interval of triptorelin for post-operative endometriosis
article
OA: closed
CC0
AI-generated summary
Administering triptorelin every five weeks post-operatively for stage 3-4 endometriosis showed similar estrogen levels but a delayed menstrual recovery compared to the four-week interval.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective
To evaluate the feasibility of prolonged administration interval of triptorelin for post-operative endometriosis.
Methods
89 women with stage 3-4 endometriosis were randomly assigned to a study group (42 cases) and a control group (47 cases). The observation group were intramuscularly injected 3.75 mg triptorelin every 5 weeks after operation, and the control group every 4 weeks.
Results
During the treatment, there was no statistical difference in estrogen level between these two groups. The menstruation recovery time was (234.0±17.1) days in study group, and was (209.0±13.6) days in control group.
Conclusions
The injection of triptorelin every 5 weeks after operation for patients with stage 3-4 endometriosis is feasible.
Key words:
Endometriosis; Ovarian chocolate cyst; Gonadotropin-releasing hormone agonist; Triptorelin
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK